Previous Close | 4.0946 |
Open | 4.1246 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 4.1246 - 4.1246 |
52 Week Range | 3.4000 - 4.5000 |
Volume | |
Avg. Volume | 41,683 |
Market Cap | 37.667B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 29.46 |
EPS (TTM) | 0.1400 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.08 (1.83%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | N/A |
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.